All products
By area
By ATC classifier
! Pharmacovigilance

VIRORIB capsule

The active substance:


Indications for use:

In combination with peginterferon alfa-2a or with interferon alfa-2a for the treatment of chronic hepatitis C in adult patients, in serum of which positive HCV RNA test is determined, including patients in compensation stage of cirrhosis.

Combined therapy by Virorib® and peginterferon alfa-2a in patients, in which the preceding treatment by interferon alfa-2a (pegylated or non-pegylated) as monotherapy or in combination with ribavirin was ineffective.

1 capsule contains ribavirin 200 mg; Antiviral medication of direct action.

For detailed information, please see instruction for medical use.